DNLI vs PNC · $2.11B cap vs P/E 14, rev $23.10B
Denali Therapeutics Inc (DNLI) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Latest reported DNLI revenue for 2024-12-31 was $0. Net income was -$422.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. DNLI currently screens at market cap $2.11B.
Latest reported PNC revenue for 2025-12-31 was $23.10B. Net income was $7.00B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
DNLI currently screens at market cap $2.11B. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the DNLI and PNC stock pages for the full models.
Not investment advice.